• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类免疫缺陷病毒衍生载体颗粒对造血靶细胞的长期黏附会导致体外和体内的二次转导。

Prolonged adherence of human immunodeficiency virus-derived vector particles to hematopoietic target cells leads to secondary transduction in vitro and in vivo.

作者信息

Pan Yung-Wei, Scarlett Jarrad M, Luoh Tammy T, Kurre Peter

机构信息

Department of Pediatrics, Oregon Health and Science University, Portland, OR 97239, USA.

出版信息

J Virol. 2007 Jan;81(2):639-49. doi: 10.1128/JVI.01089-06. Epub 2006 Oct 11.

DOI:10.1128/JVI.01089-06
PMID:17035328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1797443/
Abstract

Human immunodeficiency virus type 1-derived lentivirus vectors bearing the vesicular stomatitis virus G (VSV-G) envelope glycoprotein demonstrate a wide host range and can stably transduce quiescent hematopoietic stem cells. In light of concerns about biosafety and potential germ line transmission, they have been used predominantly for ex vivo strategies, thought to ensure the removal of excess surface-bound particles and prevent in vivo dissemination. Studies presented here instead reveal prolonged particle adherence after ex vivo exposure, despite serial wash procedures, with subsequent transduction of secondary target cells in direct and transwell cocultures. We explored the critical parameters affecting particle retention and transfer and show that attachment to the cell surface selectively protects virus particles from serum complement-mediated inactivation. Moreover, studies with nonmyeloablated murine recipients show that transplantation of vector-exposed, washed hematopoietic cells results in systemic dissemination of functional VSV-G/lentivector particles. We demonstrate genetic marking by inadvertent transfer of vector particles and prolonged expression of transgene product in recipient tissues. Our findings have implications for biosafety, vector design, and cell biology research.

摘要

携带水疱性口炎病毒G(VSV-G)包膜糖蛋白的1型人类免疫缺陷病毒衍生慢病毒载体具有广泛的宿主范围,并且能够稳定转导静止的造血干细胞。鉴于对生物安全性和潜在种系传播的担忧,它们主要用于体外策略,认为这样能确保去除多余的表面结合颗粒并防止体内传播。然而,本文所呈现的研究揭示,尽管进行了系列洗涤程序,但体外暴露后颗粒仍会长期黏附,随后在直接共培养和Transwell共培养中对次级靶细胞进行转导。我们探究了影响颗粒保留和转移的关键参数,并表明附着于细胞表面可选择性地保护病毒颗粒免受血清补体介导的失活作用。此外,对未进行骨髓消融的小鼠受体的研究表明,移植经载体处理并洗涤过的造血细胞会导致功能性VSV-G/慢病毒载体颗粒的全身传播。我们通过载体颗粒的意外转移证明了基因标记,并在受体组织中证明了转基因产物的长期表达。我们的发现对生物安全性、载体设计和细胞生物学研究具有重要意义。

相似文献

1
Prolonged adherence of human immunodeficiency virus-derived vector particles to hematopoietic target cells leads to secondary transduction in vitro and in vivo.人类免疫缺陷病毒衍生载体颗粒对造血靶细胞的长期黏附会导致体外和体内的二次转导。
J Virol. 2007 Jan;81(2):639-49. doi: 10.1128/JVI.01089-06. Epub 2006 Oct 11.
2
Efficient human immunodeficiency virus-based vector transduction of unstimulated human mobilized peripheral blood CD34+ cells in the SCID-hu Thy/Liv model of human T cell lymphopoiesis.在人类T细胞淋巴细胞生成的SCID-hu Thy/Liv模型中,基于高效人类免疫缺陷病毒载体转导未刺激的人类动员外周血CD34+细胞。
Hum Gene Ther. 2001 Mar 1;12(4):401-13. doi: 10.1089/10430340150504028.
3
High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.使用基于1型人类免疫缺陷病毒[免疫缺陷的校正]慢病毒载体(包含内部脾脏灶形成病毒启动子)在造血重建细胞中实现高效转导和基因表达。
Hum Gene Ther. 2002 May 1;13(7):803-13. doi: 10.1089/10430340252898984.
4
Human immunodeficiency virus type 1 vectors with alphavirus envelope glycoproteins produced from stable packaging cells.由稳定包装细胞产生的带有甲病毒包膜糖蛋白的1型人类免疫缺陷病毒载体。
J Virol. 2005 Feb;79(3):1765-71. doi: 10.1128/JVI.79.3.1765-1771.2005.
5
Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus.1型人类免疫缺陷病毒衍生的慢病毒载体,其包膜糖蛋白来自罗斯河病毒和Semliki森林病毒,以此构建假型病毒载体。
J Virol. 2004 Feb;78(3):1421-30. doi: 10.1128/jvi.78.3.1421-1430.2004.
6
Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein.用RD114-TR嵌合包膜糖蛋白假型化的慢病毒载体转导人造血干细胞。
Hum Gene Ther. 2007 Sep;18(9):811-20. doi: 10.1089/hum.2006.138.
7
RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.RD114 包膜蛋白为假型慢病毒载体提供了一种有效且通用的方法。
Exp Biol Med (Maywood). 2010 Oct;235(10):1269-76. doi: 10.1258/ebm.2010.010053. Epub 2010 Sep 27.
8
A novel lentivirus vector derived from apathogenic simian immunodeficiency virus.一种源自致病性猿猴免疫缺陷病毒的新型慢病毒载体。
Virology. 2001 Dec 20;291(2):191-7. doi: 10.1006/viro.2001.1183.
9
Rapid 1-hour transduction of whole bone marrow leads to long-term repopulation of murine recipients with lentivirus-modified hematopoietic stem cells.对全骨髓进行1小时的快速转导可使慢病毒修饰的造血干细胞长期重建小鼠受体。
Gene Ther. 2006 Feb;13(4):369-73. doi: 10.1038/sj.gt.3302659.
10
Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro.用杆状病毒gp64假型化的慢病毒载体可在体内有效地转导小鼠细胞,并在体外对造血细胞类型表现出嗜性限制。
Gene Ther. 2004 Feb;11(3):266-75. doi: 10.1038/sj.gt.3302170.

引用本文的文献

1
Simian Immunodeficiency Virus-Based Virus-like Particles Are an Efficient Tool to Induce Persistent Anti-SARS-CoV-2 Spike Neutralizing Antibodies and Specific T Cells in Mice.基于猿猴免疫缺陷病毒的病毒样颗粒是在小鼠中诱导持久性抗SARS-CoV-2刺突中和抗体和特异性T细胞的有效工具。
Vaccines (Basel). 2025 Feb 21;13(3):216. doi: 10.3390/vaccines13030216.
2
Exploiting hosts and vectors: viral strategies for facilitating transmission.利用宿主和载体:病毒促进传播的策略。
EMBO Rep. 2024 Aug;25(8):3187-3201. doi: 10.1038/s44319-024-00214-6. Epub 2024 Jul 24.
3
Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers.递送膜锚定的天然样HIV-1包膜三聚体的整合酶缺陷型慢病毒载体的持续免疫原性。
NPJ Vaccines. 2022 Apr 21;7(1):44. doi: 10.1038/s41541-022-00465-1.
4
Envelope-Specific Adaptive Immunity following Transplantation of Hematopoietic Stem Cells Modified with VSV-G Lentivirus.用VSV-G慢病毒修饰的造血干细胞移植后的包膜特异性适应性免疫
Mol Ther Methods Clin Dev. 2020 Oct 10;19:438-446. doi: 10.1016/j.omtm.2020.10.002. eCollection 2020 Dec 11.
5
A Microfluidic Device to Enhance Viral Transduction Efficiency During Manufacture of Engineered Cellular Therapies.一种微流控装置,用于提高工程细胞疗法制造过程中的病毒转导效率。
Sci Rep. 2019 Oct 22;9(1):15101. doi: 10.1038/s41598-019-50981-9.
6
Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I.人类基因组编辑造血干细胞在表型上纠正黏多糖贮积症 I 型。
Nat Commun. 2019 Sep 6;10(1):4045. doi: 10.1038/s41467-019-11962-8.
7
High-Efficiency Lentiviral Transduction of Human CD34 Cells in High-Density Culture with Poloxamer and Prostaglandin E2.泊洛沙姆和前列腺素E2用于高密度培养的人CD34细胞的高效慢病毒转导
Mol Ther Methods Clin Dev. 2019 Jan 25;13:187-196. doi: 10.1016/j.omtm.2019.01.005. eCollection 2019 Jun 14.
8
HIV latency can be established in proliferating and nonproliferating resting CD4+ T cells in vitro: implications for latency reversal.HIV 潜伏可以在体外增殖和非增殖的静止 CD4+T 细胞中建立:对潜伏期逆转的影响。
AIDS. 2019 Feb 1;33(2):199-209. doi: 10.1097/QAD.0000000000002075.
9
Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens.整合缺陷型慢病毒载体作为流感抗原疫苗传递平台。
Front Immunol. 2018 Feb 5;9:171. doi: 10.3389/fimmu.2018.00171. eCollection 2018.
10
Amplification and propagation of interleukin-1β signaling by murine brain endothelial and glial cells.小鼠脑内皮细胞和神经胶质细胞对白介素-1β信号的放大与传导
J Neuroinflammation. 2017 Jul 1;14(1):133. doi: 10.1186/s12974-017-0908-4.

本文引用的文献

1
In vivo transduction by intravenous injection of a lentiviral vector expressing human ADA into neonatal ADA gene knockout mice: a novel form of enzyme replacement therapy for ADA deficiency.通过静脉注射表达人腺苷脱氨酶(ADA)的慢病毒载体对新生期ADA基因敲除小鼠进行体内转导:一种用于ADA缺乏症的新型酶替代疗法。
Mol Ther. 2006 Jun;13(6):1110-20. doi: 10.1016/j.ymthe.2006.02.013. Epub 2006 May 2.
2
Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells.利用抗原特异性T细胞搭载实现肿瘤靶向性治疗性病毒载体的全身递送。
Nat Med. 2005 Oct;11(10):1073-81. doi: 10.1038/nm1297. Epub 2005 Sep 18.
3
Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX.通过人凝血因子IX的干细胞基因递送在血友病B小鼠模型中实现永久性部分表型纠正和耐受性
Gene Ther. 2006 Jan;13(2):117-26. doi: 10.1038/sj.gt.3302638.
4
Novel lentiviral vectors displaying "early-acting cytokines" selectively promote survival and transduction of NOD/SCID repopulating human hematopoietic stem cells.展示“早期作用细胞因子”的新型慢病毒载体可选择性促进 NOD/SCID 重建造血干细胞的存活和转导。
Blood. 2005 Nov 15;106(10):3386-95. doi: 10.1182/blood-2004-12-4736. Epub 2005 Aug 2.
5
Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation.在最小限度体外操作条件下,慢病毒载体和嗜肝性逆转录病毒载体对高度纯化的小鼠造血干细胞的转导效率。
Mol Ther. 2005 Jun;11(6):932-40. doi: 10.1016/j.ymthe.2005.01.005.
6
Gene therapy for the hemoglobin disorders.血红蛋白疾病的基因治疗。
Semin Hematol. 2004 Oct;41(4):279-86. doi: 10.1053/j.seminhematol.2004.07.004.
7
Genetic manipulation of hematopoietic stem cells.造血干细胞的基因操作。
Semin Hematol. 2004 Oct;41(4):257-71. doi: 10.1053/j.seminhematol.2004.07.002.
8
In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions.在最小损伤条件下小鼠间充质干细胞向多种细胞类型的体内贡献。
J Cell Sci. 2004 Nov 1;117(Pt 23):5655-64. doi: 10.1242/jcs.01488. Epub 2004 Oct 19.
9
High-level beta-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells.人脐带血干细胞经慢病毒转导后的高水平β-珠蛋白表达及基因内优先整合
J Clin Invest. 2004 Oct;114(7):953-62. doi: 10.1172/JCI21838.
10
Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus.磷脂酰丝氨酸不是水疱性口炎病毒的细胞表面受体。
J Virol. 2004 Oct;78(20):10920-6. doi: 10.1128/JVI.78.20.10920-10926.2004.